RxDoctor Payments Data
★ My doctorsLook up a doctor →

Lew Schon, MD

Foot and Ankle Surgery · Baltimore, MDNPI 1740224930

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (59.9%), consulting fees and education — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Zimmer Biomet at 52.2% of the total. Among foot and ankle surgery clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$752,193in general payments, 2019–2025

Across 490 payments — averaging $1535.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$392K
  • Arthrex$213K
  • Paragon 28, Inc.$71K
  • DJO, LLC$54K
  • Stryker$7K
  • Carestream Health, Inc.$7K
  • plus $8K from 19 others
$21,285in research payments, 2019–2025

Across 4 payments — averaging $5321.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ferring International Pharmascience Center US$14K
  • Paragon 28, Inc.$7K
  • Stryker$200
$8,579in ownership & investment interests, 2019–2025

Across 4 payments — averaging $2144.75 each. An ownership or investment interest held by the physician or an immediate family member.

  • Curvebeam LLC$9K

What the payments were for

  • Royalty or licence$450,41560%
  • Consulting fees$215,19429%
  • Speaking & faculty fees$3,0000%
  • Travel & lodging$20,2223%
  • Food & beverage$7,7091%
  • Education$55,4157%
  • Entertainment$2380%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Zimmer Biomet289$392,313
Arthrex30$212,542
Paragon 28, Inc.64$71,136
DJO, LLC29$53,708
Stryker(2 entities)32$7,461
Carestream Health, Inc.16$7,316
Avitus Orthopaedics, Inc.2$2,000
Mirus, LLC3$1,500
Supreme Orthopedic Systems, LLC2$1,211
Southtech Orthopedics1$1,200
Arteriocyte Medical Systems, Inc.2$279
Ossio Inc2$250
Curvebeam LLC1$238
Acuitive Technologies, Inc1$154
Treace Medical Concepts, Inc.2$146
Medical Device Business Services, Inc.1$137
Davol Inc.1$133
Johnson & Johnson3$121
Biocomposites Inc2$119
GRT US Holding, Inc.1$106
Baxter Healthcare1$40
Linvatec Corporation2$34
Averitas Pharma Inc.1$18
Smith+Nephew1$17
Solventum Corporation1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$752,193 in reported general payments places this provider in the 95th percentile of 182 foot and ankle surgery providers in Maryland.

See all foot and ankle surgery providers in Maryland →

Medicare billing

Part B allowed, 2024
$163,255
Medicare patients
407
Services billed
1,505

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other foot and ankle surgery in Baltimore

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →